JONATHAN ROTHBERG

At Butterfly Network, we have built the world's first ultrasound-on-a-chip that's FDA cleared for 13 indications, priced at under $2000... Jonathan started his first company, CuraGen, as a graduate student at Yale in 1991. One of the first genomics companies, CuraGen went public in 1999, and at one time had a market cap of $5 billion, larger than that of American Airlines. With his next company, 454 Life Sciences, Jonathan brought to market the first new way to sequence genomes since 1980. The idea for massively parallel ("next-gen") DNA sequencing came to Jonathan when his infant son was rushed into intensive care, helping him realize the critical importance of genomics to human health. He went on to invent semiconductor chip-based sequencing with Ion Torrent, paving the way for the $1,000 Genome. His contributions to the field of sequencing have formed the basis for all subsequent next generation sequencing technologies, and he is regarded as the inventor of the technology... At..

Also known as: Butterfly Network